Table 4 Death rates for 2001–2005 and short-term trends for 1996–2005 for the top 15 cancers by sex, race, and ethnicity in the United States*
| |
All races/ethnicities
|
White
|
Black
|
API |
AI/AN (CHSDA counties)
|
Hispanic,
|
Sex/cancer site or type |
Rank |
Rate|| |
APC¶ |
Rank |
Rate|| |
APC¶ |
Rank |
Rate|| |
APC¶ |
Rank |
Rate|| |
APC¶ |
Rank |
Rate|| |
APC¶ |
Rank |
Rate|| |
APC¶ |
|
| Males |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| All sites |
|
234.4 |
–1.7# |
|
230.7 |
–1.5# |
|
313.1 |
–2.5# |
|
138.8 |
–2.0# |
|
190.0 |
–0.7 |
|
159.1 |
–1.9# |
| Lung and bronchus |
1 |
72.0 |
–2.0# |
1 |
71.3 |
–1.8# |
1 |
93.1 |
–2.8# |
1 |
37.5 |
–1.6# |
1 |
50.2 |
–2.3# |
1 |
35.0 |
–2.5# |
| Prostate |
2 |
26.7 |
–4.1# |
2 |
24.6 |
–4.0# |
2 |
59.4 |
–4.0# |
4 |
11.0 |
–4.1# |
2 |
21.1 |
–1.9 |
2 |
20.6 |
–3.5# |
| Colon and rectum |
3 |
22.7 |
–2.6# |
3 |
22.1 |
–2.7# |
3 |
31.8 |
–1.6# |
3 |
14.4 |
–2.1# |
3 |
20.5 |
–1.0 |
3 |
16.5 |
–2.0# |
| Pancreas |
4 |
12.2 |
0.1 |
4 |
12.1 |
0.2# |
4 |
15.4 |
–0.9# |
6 |
8.0 |
–0.4 |
7 |
8.6 |
3.3 |
5 |
9.2 |
0.3 |
| Leukemia |
5 |
9.9 |
–0.8# |
5 |
10.2 |
–0.7# |
8 |
8.5 |
–1.8# |
8 |
5.1 |
–0.6 |
10 |
5.7 |
1.0 |
8 |
6.3 |
–1.1 |
| Non-Hodgkin lymphoma |
6 |
9.3 |
–2.7# |
6 |
9.7 |
–2.6# |
11 |
6.4 |
–3.7# |
7 |
5.6 |
–3.7# |
9 |
5.8 |
–2.1 |
7 |
6.7 |
–4.3# |
| Esophagus |
7 |
7.8 |
0.5# |
8 |
7.8 |
1.3# |
7 |
9.8 |
–4.6# |
10 |
3.1 |
–3.5 |
8 |
7.1 |
5.3# |
10 |
4.2 |
–2.1# |
| Urinary bladder |
8 |
7.5 |
–0.3# |
7 |
7.9 |
–0.2 |
13 |
5.4 |
–1.0 |
11 |
2.9 |
0.0 |
13 |
2.9 |
** |
11 |
4.0 |
–1.0 |
| Liver and intrahepatic bile duct |
9 |
7.3 |
2.1# |
9 |
6.7 |
2.1# |
6 |
10.3 |
2.5# |
2 |
15.2 |
–1.3# |
4 |
10.6 |
1.4 |
4 |
11.1 |
1.5# |
| Kidney and renal pelvis |
10 |
6.0 |
–0.4 |
10 |
6.2 |
–0.3 |
12 |
6.1 |
–0.5 |
13 |
2.4 |
–4.0# |
6 |
9.3 |
0.2 |
9 |
5.3 |
0.5 |
| Stomach |
11 |
5.7 |
–3.7# |
12 |
5.0 |
–3.8# |
5 |
11.5 |
–3.8# |
5 |
10.1 |
–3.9# |
5 |
9.9 |
0.1 |
6 |
8.7 |
–2.6# |
| Brain and other nervous system |
12 |
5.4 |
–1.0# |
11 |
5.7 |
–1.0# |
15 |
3.2 |
–0.4 |
12 |
2.6 |
2.2 |
14 |
2.8 |
3.1 |
13 |
3.4 |
–0.5 |
| Myeloma |
13 |
4.6 |
–1.1# |
14 |
4.3 |
–0.9# |
9 |
8.3 |
–2.0# |
14 |
1.9 |
–2.9# |
11 |
4.6 |
1.8 |
12 |
3.6 |
–1.8 |
| Oral cavity and pharynx |
14 |
4.0 |
–1.9# |
15 |
3.8 |
–1.7# |
10 |
6.7 |
–3.0# |
9 |
3.3 |
–3.0# |
12 |
3.8 |
** |
14 |
2.6 |
–4.0# |
| Melanoma of the skin |
15 |
3.9 |
–0.2 |
13 |
4.4 |
–0.1 |
24 |
0.5 |
–0.4 |
19 |
0.5 |
** |
16 |
1.5 |
** |
17 |
0.9 |
–3.8# |
| Larynx |
16 |
2.3 |
–2.3# |
16 |
2.1 |
–2.0# |
14 |
4.8 |
–3.3# |
16 |
0.8 |
–3.3 |
15 |
2.1 |
** |
15 |
1.9 |
–4.1# |
| Soft tissue including heart |
17 |
1.4 |
–2.1# |
18 |
1.4 |
–1.9# |
16 |
1.5 |
–3.1# |
15 |
0.9 |
–2.5 |
18 |
1.1 |
** |
16 |
1.0 |
–3.2# |
| Females |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| All sites |
|
159.9 |
–1.0# |
|
159.2 |
–0.9# |
|
186.8 |
–1.2# |
|
95.9 |
–1.1# |
|
142.0 |
–0.2 |
|
105.3 |
–1.1# |
| Lung and bronchus |
1 |
41.0 |
0.1 |
1 |
42.0 |
0.2 |
1 |
39.9 |
0.1 |
1 |
18.5 |
–0.7 |
1 |
33.8 |
2.9# |
2 |
14.6 |
–0.5 |
| Breast |
2 |
25.0 |
–2.1# |
2 |
24.4 |
–2.2# |
2 |
33.5 |
–1.5# |
2 |
12.6 |
0.0 |
2 |
17.1 |
1.0 |
1 |
15.8 |
–2.5# |
| Colon and rectum |
3 |
15.9 |
–2.5# |
3 |
15.3 |
–2.6# |
3 |
22.4 |
–1.9# |
3 |
10.2 |
–2.1# |
3 |
14.2 |
–2.2 |
3 |
10.9 |
–0.9 |
| Pancreas |
4 |
9.3 |
0.2# |
5 |
9.0 |
0.4# |
4 |
12.4 |
–0.7# |
4 |
6.9 |
0.5 |
5 |
7.2 |
–1.3 |
4 |
7.6 |
0.7 |
| Ovary |
5 |
8.8 |
–0.1 |
4 |
9.2 |
–0.1 |
5 |
7.5 |
–0.1 |
7 |
4.9 |
0.7 |
4 |
7.5 |
0.6 |
5 |
6.0 |
0.4 |
| Non-Hodgkin lymphoma |
6 |
5.9 |
–3.2# |
6 |
6.2 |
–3.3# |
11 |
4.2 |
–2.3# |
8 |
3.8 |
–1.4 |
8 |
4.9 |
0.5 |
8 |
4.6 |
–2.8# |
| Leukemia |
7 |
5.6 |
–1.1# |
7 |
5.7 |
–1.0# |
9 |
5.2 |
–1.3# |
9 |
3.0 |
–2.1# |
10 |
4.1 |
** |
9 |
4.0 |
–1.5# |
| Uterine corpus and uterus NOS |
8 |
4.1 |
0.1 |
8 |
3.9 |
0.1 |
6 |
7.1 |
0.3 |
10 |
2.4 |
0.4 |
13 |
3.1 |
** |
11 |
3.2 |
0.0 |
| Brain and other nervous system |
9 |
3.6 |
–1.3# |
9 |
3.9 |
–1.1# |
16 |
2.1 |
–1.8# |
12 |
1.5 |
–0.1 |
16 |
1.4 |
** |
14 |
2.4 |
0.1 |
| Liver and intrahepatic bile duct |
10 |
3.1 |
1.1# |
10 |
2.9 |
1.0# |
12 |
3.9 |
0.6 |
5 |
6.6 |
0.5 |
6 |
6.6 |
3.2 |
6 |
5.1 |
1.6# |
| Myeloma |
11 |
3.0 |
–1.2# |
12 |
2.8 |
–1.1# |
7 |
6.0 |
–1.7# |
13 |
1.4 |
–1.9 |
12 |
3.6 |
–3.7 |
12 |
2.6 |
–1.7 |
| Stomach |
12 |
2.9 |
–2.7# |
13 |
2.5 |
–2.8# |
8 |
5.5 |
–3.3# |
6 |
5.9 |
–4.4# |
7 |
5.2 |
–3.5 |
7 |
5.0 |
–2.0# |
| Kidney and renal pelvis |
13 |
2.7 |
–0.5# |
11 |
2.8 |
–0.4 |
15 |
2.7 |
–0.6 |
15 |
1.2 |
–1.2 |
9 |
4.3 |
–0.8 |
13 |
2.4 |
0.8 |
| Uterine cervix |
14 |
2.5 |
–3.4# |
14 |
2.3 |
–3.2# |
10 |
4.7 |
–4.3# |
11 |
2.2 |
–5.2# |
11 |
3.7 |
–2.8 |
10 |
3.2 |
–3.1# |
| Urinary bladder |
15 |
2.3 |
–0.8# |
15 |
2.2 |
–0.6# |
14 |
2.8 |
–1.7# |
16 |
1.0 |
–0.4 |
18 |
1.2 |
** |
15 |
1.4 |
0.4 |
| Esophagus |
17 |
1.7 |
–0.9# |
17 |
1.6 |
–0.2 |
13 |
2.8 |
–3.9# |
18 |
0.8 |
–2.0 |
15 |
1.6 |
** |
17 |
0.9 |
–3.5# |
| Oral cavity and pharynx |
18 |
1.5 |
–2.4# |
18 |
1.5 |
–2.2# |
17 |
1.6 |
–4.5# |
14 |
1.4 |
–0.5 |
17 |
1.3 |
** |
19 |
0.8 |
–1.9 |
| Gallbladder |
20 |
0.8 |
–2.5# |
20 |
0.8 |
–2.6# |
19 |
1.0 |
–1.6 |
17 |
0.8 |
–3.5 |
14 |
2.2 |
** |
16 |
1.3 |
–5.4# |
|
* API = Asian/Pacific Islander; AI/AN = American Indian/Alaska Native; IHS = Indian Health Service; CHSDA = IHS Contract Health Service Delivery Area; APC = annual percent change; NOS = not otherwise specified. Source: National Center for Health Statistics, 2005 Mortality Special Research File.
Cancers are sorted in descending order according to sex-specific rates for all races and ethnicities. More than 15 cancers may appear under males and females to include the top 15 cancers in every race and ethnicity group.
White, black, API, and AI/AN (CHSDA counties) populations include Hispanic and non-Hispanic; the race and ethnicity categories are not mutually exclusive.
Data for Hispanic exclude Maine, Minnesota, New Hampshire, North Dakota, and Oklahoma.
|| Rates (per 100 000 persons) were age standardized to the 2000 US standard population.
¶ APC is based on rates that were age standardized to the 2000 US standard population.
# APC is statistically significantly different from zero (two-sided P < .05, calculated using a t test).
** Statistic could not be calculated. The annual percent change is based on fewer than 10 cancer cases for at least 1 y within the time interval.
